News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
LUNGevity Foundation Highlighted FDA Approval on Telisotuzumab Vedotin (EMRELIS) in Advanced NSCLC
nsclc.lungevity.org
Jun 1, 2025, 08:52

LUNGevity Foundation Highlighted FDA Approval on Telisotuzumab Vedotin (EMRELIS) in Advanced NSCLC

LUNGevity Foundation shared a post on LinkedIn:

“Despite the progress we have seen in the treatment of lung cancer, we need more options for people whose treatments stop working,” said Upal Basu Roy, PhD, MPH, executive director of research, LUNGevity Foundation. “This approval is a welcomed targeted therapy for those with high c-Met protein overexpressing late-stage, non-small cell lung cancer who have seen very limited treatment innovation in the last decade.”

Read More on nsclc.lungevity.org.

Read OncoDaily’s Special Article: FDA Approval for Telisotuzumab Vedotin (EMRELIS™)

fda approval Telisotuzumab Vedotin LUNGevity Foundation

advanced NSCLC cancer FDA LUNGevity Foundation OncoDaily Oncology Telisotuzumab Vedotin
Special Coverage
Blog Posts
Aug 18, 2025, 20:57
Niranjala Siriwardena: Why I’m Fighting for Australia’s First Workplace Cancer Survivorship Policy
Voices
Aug 18, 2025, 20:47
Wafaa M Rashed: Final Words to the Tenth Cohort of the Policy Advocacy in Genetics and Genomics Course
Blog Posts
Aug 18, 2025, 20:36
Gashaw Arega: The Beginning of Childhood Cancer Care in Ethiopia
Opinion
Aug 18, 2025, 20:22
Soumen Das: From LMIC to LRS - Rethinking Global Health
Health Policy
Aug 18, 2025, 20:12
Niranjala Siriwardena: Building Australia’s First Workplace Cancer Survivorship Policy
Voices
Aug 18, 2025, 20:02
Confronting Stigma at the Crossroads of Hepatitis and Cancer - European Cancer Organisation
Positive
Aug 18, 2025, 19:53
Erin and Chloe Raise £800 for Lung Cancer Research - Oncogene Cancer Research
Blog Posts
Aug 18, 2025, 19:28
Liz O’Riordan: Everything You Need to Know about Breast Cancer Recurrence
Blog Posts
Aug 18, 2025, 19:17
Matteo Bauckneht: Pitfalls in PSMA-Based RLT - A Case-Based Review at EANM25
Insight
Aug 18, 2025, 18:55
NCODA Brings the BREAKWATER Trial into Practice
Blog Posts
Aug 18, 2025, 18:20
Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025
Insight
Aug 18, 2025, 18:09
Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer